55 companies in the directory build clinic and practice-management software under BioTech. They cluster around BioTech, MedTech and Pharmaceuticals. Acie® Inc., Aethl Bio, Inc. and Alys Pharmaceuticals are among them. 48 have disclosed funding. Founding years run from 2004 to 2025.
55 products
World's first AI-powered skin-sensing device for everyday use
Acie is a Seed-stage healthtech startup building the world's first AI-powered skin-sensing device for everyday use. Like “Apple Health for Skincare”, Acie’s solution includes a smart, all-in-one skincare device connecte…
Advancing the Future of Wound Care
At Aethl, we are pushing the boundaries of what’s possible in wound and skin care. For millions living with chronic wounds, recovery is often slow, painful, and disruptive. Patients and clinicians face limited options,…
An Innovation Leader in Immuno-Dermatology
Launched in February 2024, Alys Pharmaceuticals is an innovation leader in immuno-dermatology, co-founded by Medixci and world-leading dermatology and scientific experts. Originating from the aggregation of six asset-ce…
Biotechnology Innovation
Avalor Tx is a startup biotech company focused on developing breakthrough disease-modifying medicines for significant unmet medical needs that are driven by chronic inflammation and that are life-threatening and/or impo…
Transforming Hypertrophic Cardiomyopathy Care
Braveheart Bio is a late clinical-stage biotechnology company developing novel therapeutics for hypertrophic cardiomyopathy and related conditions. The company is backed by experienced life science investors including A…
Celestia Life Sciences | Decoding Complex Chronic Conditions
Celestia Life Science is developing a clinical bioinformatics platform and laboratory for generating a clearer understanding of complex chronic conditions, such as Long COVID, POTS, and endometriosis.
Improving Transplant Recipient Outcomes
Eurofins Transplant Genomics develops molecular diagnostic tests for organ transplant monitoring using peripheral blood gene expression profiling and dd-cfDNA analysis. The company serves transplant centers, nephrologis…
FYR is revolutionizing the ability to dynamically observe disease and treatment response to produce better biomarkers, trials, drugs and outcomes. FYR’s EV-Omics (EVO) platform leverages its proprietary technology, SPAR…
We aim to improve the lives of millions of people living with obesity and related comorbidities by advancing a pipeline of best-in-class biologics. We combine cutting-edge protein engineering with deep mechanistic ins…
Innovative Therapeutics for Alzheimer's and Parkinson's Disease
GISMO THERAPEUTICS INC. is a privately funded biotech start-up company incorporated in 2011. The company is developing novel oral therapeutics for Alzheimer’s and Parkinson's Disease, based on a novel hypothesis and a n…
Revolutionizing Peri-Implant Disease Diagnostics
Integral Dental is a dental diagnostic company targeting peri-implant disease through AI-derived metagenomics. Our product, Oracle-PI, offers a highly accurate peri-implant disease diagnosis through the comprehensive an…
Circular single-stranded DNA templates: high-fidelity, immune-quiet, scalable.
Kano Therapeutics is a biotech startup enabling safe, effective, and flexible correction of gene-length stretches of DNA through a new class of biomaterials: circular single-stranded DNA. By building a “one stop shop” p…
drug discovery and development company investigating new molecular targets and developing novel therapeutics to treat metabolic diseases
Metabolic Solutions Development Company (MSDC) is a drug discovery and development company investigating new molecular targets and developing novel therapeutics to treat metabolic diseases associated with age-related mi…
Detect disease earlier with a single blood test
THE PROBLEM 45% of Americans suffer from at least one chronic disease. The biological processes of chronic diseases, however, progresses over decades. In fact, patients presenting common symptoms of fatigue or dizziness…
Advancing First-in-Class Therapies Into Clinical Development
The mission of Myosin Therapeutics, Inc. is to improve health outcomes through the development of novel pharmacotherapies targeting members of the myosin family of molecular motors. Myosin Therapeutics is positioned as…
Building intelligent platforms for biological analysis, clinical decision support, and next-generation therapeutic development.
NanoCure AI is a Texas-based oncology MedTech company building cellular-intelligence systems for hematologic malignancies, blood disorders, and future extracorporeal intervention. Our platform starts with software: a ha…
Neoclease | Gene Editing with AI Precision
Neoclease is a biotechnology company pioneering AI-designed gene-editing therapies optimized for individual genes. Using a proprietary platform that integrates generative protein models with synthetic biology, Neoclease…
Welcome to Neuronity
Neuronity is a biotech company dedicated to revolutionizing the treatment of neurodegenerative diseases. With a focus on age-related neurological disorders, such as Parkinson's disease, our cutting-edge gene and cell th…
Revolutionary Immune Reprogramming Platform
Novastra Therapeutics is a Boston-headquartered, clinical-stage biotechnology company pioneering Next-Generation Immune Reprogramming Therapy (XIRT) for solid tumors. We are engineering a paradigm shift beyond tradition…
OncoPrecision — Precision is personal.
OncoPrecision is a precision oncology company engineering first-in-class antibody-drug conjugates (ADCs) and bispecific antibodies for hard-to-treat cancers. We start where other drugs fail — studying how cancer cells e…
ORGANOID PHENOTYPING PLATFORM
Orbits Oncology is bringing patient insights into the heart of early cancer drug development and personalized medicine. We transform patient tumor data into digital patient surrogates to help cancer researchers make bet…
Revolutionizing drug discovery with mRNA display
PeptiFinder Biotech, Inc. is a Massachusetts-based biotech startup offering an mRNA display-centered drug discovery platform and delivering groundbreaking and cost-effective target-to-hit and hit-to-lead optimization so…
AI driven precision obesity medicine
Phenomix Sciences is a precision medicine obesity biotechnology pioneer on a mission to conquer obesity globally through the science of phenotyping, the understanding of how genes combined with environmental and behavio…
First-of-its-kind ACES implant to treat recurrent pleural effusions
Pleural Dynamics is a Minneapolis based medical device start-up focused on developing best in class solutions for chronic, recurrent fluid collections within the body. Our flagship product, ACES (the Automatic Continuou…
A new systems-level approach to cancer therapeutics
SyzOnc develops STEM3, an integrated platform for solid tumor drug discovery that maps tumor ecosystems using multi-modal tissue data and matrix biology, creates cancer type-specific AI/ML models, and identifies protein…
Contraception without the side effects of pills, devices, or implants
Yaso Therapeutics develops a non-hormonal contraceptive gel using its patented PPCM drug platform, currently in Phase 1 clinical trials. The multipurpose platform uses nanoscale delivery to create a barrier against viru…
Designing the future of programmable biology
Acrobat Genomics builds AI-driven protein and genome engineering platforms for pharma, biotech, and research institutions. The company's AcrobaTx Engine is a closed-loop system that uses AI to propose therapeutic candid…
AivoCode is an emerging biotech startup pioneering novel platform technologies to improve treatment and management of neurological diseases by promoting neuroprotection and blocking neuroinflammation.
AivoCode is a neuroscience-focused biotech startup that is pioneering the development of innovative and broad platform technologies to improve the treatment and management of neurological diseases such as brain injury,…
We now know that immune cells – not only in the body’s periphery but especially in the brain – can produce autoantibodies that cause severe neurological and psychiatric diseases. Founded to explore the latest discoverie…
Blissgene Therapeutics is a pioneering biotech startup on a bold mission to redefine the treatment of chronic pain, anxiety, and depression. We are on a quest of building gene therapies designed to address the root caus…
Duo Oncology, founded by oncologists, is developing tumor-penetrating nanomedicines to upgraded the foundations of cancer medicine. Duo’s patented platform prodrug chemistry releases creates nanomedicines that penetrate…
High Performance Absorbable Metal Implants
Entirety Biomedical is working to become the standard of care in ortho fixation implants, starting with maxillofacial and extremities, to offer cosmetic trauma and reconstruction surgery patients pain-free restoration o…
Transforming Cancer Therapy with Precision Epigenetics
Episteme Prognostics is a precision medicine company pioneering epigenetic diagnostics to transform how cancer therapy is selected and delivered. Our mission is to help oncologists identify which patients will truly ben…
Building The Future of At-Home Diagnostics
Exactics is a biotech startup committed to developing rapid, reliable, and cost-effective at-home diagnostic technologies for infectious diseases. Our flagship product is TiCK Test, the first ever fully at-home screenin…
Next-generation epigenetic / AI diagnostic platform for infectious disease
GNOMX was founded to commercialize host response epigenetic diagnostics based on research funded by a $46 million DARPA ECHO contract to an academic consortium led by the Icahn School of Medicine at Mount Sinai, Yale Un…
Gordon Bioscience
Gordion Bioscience has built a proprietary patient-derived dependency map across 20,000 genes and 26 cancer types - translating real tumor biology into pipeline decisions.Standard preclinical models (CRISPR screens, cel…
Long-Acting Medicines to Transform Metabolic Health
Helicore Bio is developing long-acting therapies in obesity and cardiometabolic disease using our proprietary antibody-peptide conjugate platform. We have developed proprietary libraries of GLP-1R agonist and amylin rec…
Patient-driven biodiscovery platform advancing immune biology with patients at the center
ImYoo is debugging the human immune system. By coupling at-home blood collection and single-cell RNA sequencing, we enable high resolution insights across time.
Unlocking The Power Of Metabolically-Fit Immune Cells
Is a clinical-stage biotechnology company focused on applying a novel engineering approach to develop metabolically-fit immunotherapies for patients with cancer, autoimmune, and inflammatory diseases.
Liberate Bio enables genetic medicines to access disease-driving cells directly in the body—reprogramming cellular behavior to cure disease.
Today, the biggest bottleneck in genetic medicine isn’t the power of mRNA, CRISPR, or gene therapy—it’s that we can’t get these medicines anywhere but the liver. Our RAPTOR™ platform is the first AI-driven system that m…
Revolutionary Regenerative Medicine
Metanoia: Where Regeneration Takes Center Stage At Metanoia, we're rewriting the future of healthcare. We're pioneering a revolutionary approach to regenerative medicine that targets the root cause of chronic and age-re…
Functional Precision Medicine by Nine Diagnostics
Determining treatment effectiveness, discovering new biology using AI enabled nanosensor technology. A faster path to the most effective treatment with better outcomes. We develop holistic profiles based on a patient's…
Decode Your Saliva™
Oral Genome is a saliva-based screening platform based in Carlsbad, California that delivers oral and whole-body health risk insights in under 2 minutes using point-of-care testing. The platform uses a collection sponge…
From Invisible Biology to Tomorrow’s Therapeutics
Phinomics is unlocking a hidden layer of biology—circular DNA and cryptic proteins—to power the next generation of AI in precision medicine. While others models train on a static, 1-D linear genome, we see a 3D, dynamic…
Targeted Solutions for Weight Management and Metabolic Health
Response Pharmaceuticals is developing its lead asset, RDX-002, a first-in-class weight management and cardiometabolic health drug with confirmed efficacy and safety in >550 subjects. All programs are in Phase 2 clinica…
Riboway Therapeutics: Decoding RNA to precisely control protein expression/function.
Riboway Therapeutics is a Boston-based biotech leveraging AI to decode RNA biology and develop RNA-targeted therapeutics. We aim to revolutionize how targets are drugged and make every protein druggable. Our smart RNA-t…
Sarcomatrix, Inc. is a bio-pharmaceutical company pioneering novel therapeutics that leverage our understanding of muscle biology and tissue regeneration to develop therapies that have potential for broad clinical appli…
Restoring Smell and Taste with Neuroregenerative Genetic Medicines
Senvera Therapeutics' mission is to translate compelling foundational science into transformative regenerative therapies for patients living with age-related olfactory loss, or presbyosmia, a highly prevalent disease of…
Stipple Bio is a biotechnology company harnessing epitope-level precision to create targeted cancer therapies through our proprietary Pointillist Platform, which is designed to identify tumor-specific cell surface epito…
Symbiome – skincare powered by the skin microbiome
The modern skin microbiome has lost ~80% of its microbial diversity. Symbiome is pioneering microbiome science into skin health via unique, bioactive compounds proven to restore skin’s natural resilience, longevity and…
Synamics Therapeutics is an AI-driven therapeutics company developing smarter therapies for treatment-resistant cancer. Cancer evolves. Tumors adapt, mutate, and escape treatment, leaving patients with fewer options and…
Expanding the Reach of Targeted Cancer Therapies
TwoStep Therapeutics is a biotechnology company developing a pipeline built around a versatile targeting peptide “PIP” that binds selectively to multiple tumor-associated integrins, a unique feature that enables it to d…
nChroma Bio is a clinical-stage genetic medicines company developing engineered epigenetic silencers to overcome the limitations of existing therapies and enable next-generation genomic medicines. By combining in vivo d…
Developing advanced therapeutics for vascular diseases
INGENIA Therapeutics, a biotech startup company located Watertown, MA, strives to develop durable best-in-class therapeutic antibodies, restoring dysfunctional microvessels into their healthy state in multiple ophthalmi…
Window to your future health
Toku is creating a world focused on preventive healthcare, using the eye as a window to our health. We believe every person in the world should have access to early diagnosis of health conditions before it’s too late. H…
Your clinic’s marketing team, powered by AI.On-brand ads, SEO, and social campaigns in one place.Generate your first clinic ad for free 
Get more revenue from the patients you already have.Voice and SMS that follow up until lapsed patients are back on the schedule.Book a Clincy call 
Your practice’s fractional recruiting team.Dental-only search, run end to end, with placements guaranteed for a year.Find your next hire 
Clinic Software
